sever
acut
respiratori
syndrom
coronaviru
sarscov
emerg
southern
china
late
caus
global
outbreak
fatal
rate
around
ten
year
later
second
highli
pathogen
human
cov
merscov
emerg
middl
east
spread
countri
europ
north
africa
north
america
asia
novemb
merscov
infect
least
peopl
fatal
rate
global
henc
urgent
need
identifi
antivir
drug
activ
merscov
show
clinic
avail
alcoholavers
drug
disulfiram
inhibit
papainlik
proteas
pl
pro
merscov
sarscov
find
suggest
disulfiram
act
alloster
inhibitor
merscov
pl
pro
competit
mix
inhibitor
sarscov
pl
pro
phenomenon
slowbind
inhibit
irrecover
enzym
activ
remov
unbound
disulfiram
indic
coval
inactiv
sarscov
pl
pro
disulfiram
synergist
inhibit
merscov
pl
pro
disulfiram
mycophenol
acid
impli
potenti
combin
treatment
use
three
clinic
avail
drug
human
coronavirus
cov
reput
occasion
emerg
zoonot
sourc
caus
mild
respiratori
tract
infect
late
howev
without
warn
sever
acut
respiratori
syndrom
sar
emerg
spread
coronavir
infect
becom
pandem
mainli
asia
also
region
fatal
rate
hilgenfeld
peiri
ten
year
later
sar
almost
forgotten
second
highli
pathogen
human
cov
mer
caus
sever
respiratori
syndrom
middl
east
spread
countri
due
human
activ
zaki
et
al
merscov
infect
least
peopl
high
mortal
rate
sinc
http
wwwwhointcsr
intern
travel
climat
chang
rule
possibl
emerg
addit
highli
pathogen
cov
near
futur
menacheri
et
al
menacheri
et
al
thu
develop
antivir
drug
effect
cov
urgent
need
cov
positivesens
singlestrand
rna
virus
virion
enter
host
cell
two
polyprotein
directli
translat
cleav
two
viral
proteas
main
proteas
pro
papainlik
proteas
pl
pro
perlman
netland
pl
pro
respons
cleavag
nonstructur
protein
nsp
pro
cleav
junction
downstream
perlman
netland
addit
pl
pro
deubiquitin
deisgyl
host
cell
protein
includ
interferon
factor
inactiv
pathway
nuclear
factor
activ
b
cell
result
immun
suppress
host
cell
clementz
et
al
frieman
et
al
yang
et
al
zheng
et
al
due
multipl
role
viral
replic
host
cell
control
pl
pro
consid
potenti
antivir
target
disulfiram
drug
approv
unit
state
food
drug
administr
fda
use
alcohol
avers
therapi
sinc
bell
smith
kramp
ehrenreich
moor
et
al
known
irrevers
inhibit
hepat
aldehyd
dehydrogenas
lipski
et
al
recent
studi
indic
disulfiram
abl
inhibit
enzym
methyltransferas
ureas
kinas
react
import
cystein
residu
suggest
broadspectrum
characterist
diazsanchez
et
al
galkin
et
al
paranjp
et
al
addit
clinic
trial
investig
usag
disulfiram
reactiv
latent
hiv
order
make
access
highli
activ
antiretrovir
therapi
elliott
et
al
drug
also
shown
act
zinc
ejector
respect
hepat
c
viru
protein
lee
et
al
howev
effect
disulfiram
viral
cystein
proteas
still
unknown
present
studi
demonstr
disulfiram
inhibitor
merscov
sarscov
pl
pro
furthermor
disulfiram
act
merscov
sarscov
pl
pro
via
differ
inhibit
mechan
moreov
investig
synergi
number
known
pl
pro
inhibitor
disulfiram
result
point
possibl
use
combin
treatment
involv
disulfiram
clinic
avail
drug
cov
sarscov
pl
pro
mutat
introduc
use
quikchang
mutagenesi
kit
stratagen
verifi
dna
sequenc
forward
primer
acactcatata
revers
primer
merscov
sarscov
pl
pro
sarscov
pl
pro
mutant
protein
produc
purifi
previous
describ
chou
et
al
lin
et
al
briefli
cultur
grown
h
induc
mm
isopropyl
grown
h
cell
pellet
resuspend
lysi
buffer
mm
tri
ph
mm
nacl
glycerol
triton
mm
lyse
sonic
centrifug
remov
insolubl
pellet
target
protein
purifi
fraction
solubl
protein
via
nickel
affin
chromatographi
load
onto
gelfiltr
column
ge
healthcar
equilibr
run
buffer
mm
tri
ph
mm
nacl
mm
dithiothreitol
crystal
sarscov
pl
pro
complex
glycerol
reduct
remov
disulfiram
ad
buffer
purif
process
puriti
fraction
collect
analyz
sdspage
protein
concentr
mgml
use
amicon
centrifug
filter
millipor
dub
assay
carri
previous
describ
cheng
et
al
chou
et
al
lin
et
al
fluorogen
substrat
ubafc
boston
biochem
ad
concentr
along
variou
concentr
inhibitor
mm
phosphat
ph
mixtur
incub
min
ad
coronavir
pl
pro
enzymat
activ
determin
continu
monitor
fluoresc
intens
excit
emiss
wavelength
nm
respect
data
fit
obtain
ic
accord
eq
v
initi
veloc
presenc
inhibitor
concentr
v
initi
veloc
absenc
inhibitor
n
hill
constant
addit
test
recover
activ
coronavir
pl
pro
incub
without
disulfiram
h
desalt
use
sephadex
column
dub
activ
treat
enzym
determin
presenc
absenc
mm
peptidyl
substrat
dabcylfrlkggapikgvedan
use
measur
proteolyt
activ
pl
pro
fluoresc
intens
monitor
nm
excit
nm
emiss
convert
amount
hydrolyz
substrat
base
previou
studi
cheng
et
al
chou
et
al
inhibit
studi
reaction
mixtur
contain
peptid
substrat
disulfiram
mm
phosphat
ph
merscov
pl
pro
wildtyp
sarscov
pl
pro
mutant
use
respect
ad
enzym
reaction
mixtur
fluoresc
intens
continu
monitor
increas
fluoresc
linear
least
min
thu
slope
line
repres
initi
reaction
veloc
v
data
obtain
inhibit
merscov
pl
pro
disulfiram
found
best
fit
noncompetit
inhibit
pattern
accord
eq
data
obtain
inhibit
sarscov
pl
pro
disulfiram
found
best
fit
competit
inhibit
pattern
accord
eq
mix
inhibit
pattern
accord
eq
k
cat
rate
constant
e
denot
enzym
substrat
inhibitor
concentr
k
michaelismenten
constant
interact
peptid
substrat
enzym
k
slope
inhibit
constant
enzymeinhibitor
complex
slope
inhibit
constant
enzymesubstrateinhibitor
complex
program
sigmaplot
systat
softwar
inc
usa
use
data
analysi
character
mutual
effect
disulfiram
known
pl
pro
inhibitor
activ
merscov
pl
pro
measur
without
either
mycophenol
acid
mpa
presenc
variou
concentr
disulfiram
sarscov
pl
pro
measur
without
either
nethylmaleimid
nem
presenc
variou
concentr
disulfiram
concentr
peptidyl
substrat
merscov
pl
pro
respect
substrat
sarscov
pl
pro
respect
data
obtain
reaction
fit
eq
v
initi
veloc
presenc
inhibitor
j
concentr
two
inhibitor
v
veloc
absenc
inhibitor
k
k
j
appar
dissoci
constant
two
inhibitor
measur
degre
interact
two
inhibitor
copeland
yonetani
theorel
releas
zinc
ion
coronavir
pl
pro
monitor
increas
fluoresc
emiss
zincspecif
fluorophor
thermo
fisher
scientif
lee
et
al
briefli
protein
mix
mm
phosphat
buffer
ph
concentr
respect
presenc
absenc
disulfiram
fluoresc
emiss
continu
measur
use
emiss
excit
wavelength
nm
nm
respect
perkinelm
luminesc
spectromet
chang
secondari
structur
coronavir
pl
pro
absenc
presenc
disulfiram
continu
measur
use
ellipt
nm
temperatur
ramp
jasco
spectropolarimet
protein
dissolv
mm
phosphat
buffer
ph
width
cuvett
mm
inactiv
studi
sarscov
pl
pro
mm
phosphat
buffer
ph
incub
differ
concentr
disulfiram
peptid
substrat
enzymat
activ
trace
min
progress
curv
record
show
exponenti
cours
analyz
accord
follow
integr
rate
equat
eq
copeland
v
initi
veloc
v
steadyst
veloc
displac
yaxi
replot
k
inact
versu
concentr
disulfiram
fit
satur
curv
accord
eq
copeland
k
inact
dissoci
constant
enzymedisulfiram
complex
k
max
maximum
inactiv
rate
constant
crystal
sarscov
pl
pro
complex
glycerol
obtain
sittingdrop
vapordiffus
method
pl
pro
complex
protein
mgml
incub
mm
disulfiram
h
crystal
singl
crystal
grown
reservoir
solut
contain
wv
peg
bistri
propan
ph
pl
pro
glycerol
complex
protein
purifi
addit
disulfiram
buffer
purif
process
crystal
mgml
singl
crystal
grown
reservoir
solut
contain
wv
peg
hepe
ph
crystal
cryoprotect
reservoir
solut
supplement
vv
glycerol
pl
pro
pl
pro
glycerol
respect
flashcool
liquid
nitrogen
data
collect
structur
determin
xray
diffract
data
collect
k
spxf
beamlin
nation
synchrotron
radiat
research
center
taiwan
roc
use
rayonix
ccd
detector
wavelength
diffract
imag
process
scale
packag
otwinowski
minor
structur
solv
molecularreplac
method
phaser
mccoy
et
al
use
structur
wildtyp
sarscov
pl
pro
pdb
entri
ratia
et
al
search
model
manual
rebuild
structur
model
perform
coot
emsley
cowtan
structur
refin
carri
refmac
murshudov
et
al
dataprocess
refin
statist
summar
tabl
crystal
structur
sarscov
pl
pro
complex
sarscov
pl
pro
glycerol
complex
deposit
protein
data
bank
pdb
entri
pl
pro
pl
pro
glycerol
respect
inhibit
merscov
sarscov
pl
pro
disulfiram
pl
pro
cystein
proteas
use
thiol
group
cystein
nucleophil
attack
carbonyl
group
scissil
peptid
bond
han
et
al
verma
et
al
inhibit
expect
catalyt
cystein
pl
pro
interf
modifi
cheng
et
al
chou
et
al
disulfiram
known
thiolreact
compound
coval
modifi
cystein
residu
diazsanchez
et
al
galkin
et
al
lipski
et
al
paranjp
et
al
determin
whether
disulfiram
inhibit
coronavir
pl
pro
dub
activ
merscov
sarscov
pl
pro
measur
presenc
variou
concentr
disulfiram
interestingli
disulfiram
show
dosedepend
inhibitori
effect
proteas
ic
valu
micromolar
rang
fig
next
elucid
kinet
mechan
interact
disulfiram
two
pl
pro
proteolyt
activ
enzym
measur
presenc
variou
concentr
peptidyl
substrat
disulfiram
result
fit
differ
kinet
model
competit
noncompetit
uncompetit
mix
inhibit
surprisingli
disulfiram
show
noncompetit
inhibit
pattern
merscov
pl
pro
fig
competit
inhibit
pattern
sarscov
pl
pro
fig
inconsist
quit
intrigu
sinc
two
enzym
share
similar
overal
structur
ident
catalyt
triad
baileyelkin
et
al
chou
et
al
lei
et
al
ratia
et
al
albeit
inhibit
constant
k
disulfiram
merscov
pl
pro
higher
sarscov
pl
pro
tabl
perhap
discoveri
surpris
given
disulfiram
also
noncompetit
inhibitor
citrullu
vulgari
ureas
k
diazsanchez
et
al
ic
giardia
lamblia
carbam
kinas
chen
et
al
similarli
previou
studi
mention
compound
also
differ
recognit
specif
two
pl
pro
studi
suggest
broadspectrum
potenc
disulfiram
given
versatil
show
even
two
coronavir
pl
pro
inconsist
inhibitori
effect
disulfiram
two
pl
pro
suggest
bind
mode
disulfiram
two
enzym
may
differ
verifi
multipl
inhibit
assay
use
disulfiram
known
pl
pro
inhibitor
includ
mpa
nem
perform
fig
chen
et
al
cheng
et
al
yonetani
theorel
interestingli
surprisingli
found
disulfiram
display
synergist
inhibitori
effect
either
mpa
merscov
pl
pro
line
yonetanitheorel
plot
intersect
xaxi
valu
case
fig
b
copeland
contrast
case
sarscov
pl
pro
plot
display
two
parallel
line
valu
significantli
higher
fig
suggest
bind
disulfiram
nem
mutual
exclus
sarscov
pl
pro
copeland
sinc
competit
inhibitor
pl
pro
cheng
et
al
chou
et
al
contrast
synergi
disulfiram
two
pl
pro
confirm
inconsist
inhibitori
pattern
disulfiram
fig
furthermor
mpa
previous
shown
noncompetit
inhibitor
merscov
pl
pro
work
synergist
inhibit
merscov
pl
pro
cheng
et
al
combin
result
result
regard
bind
synergi
disulfiram
mpa
fig
b
propos
disulfiram
may
occupi
third
bind
site
merscov
pl
pro
neither
site
activ
center
mpa
bind
site
next
evalu
pl
pro
inhibit
presenc
disulfiram
combin
andor
mpa
proteolyt
assay
use
peptidyl
substrat
found
ic
disulfiram
merscov
pl
pro
show
decreas
presenc
decreas
test
combin
mpa
tabl
comparison
case
disulfiram
sarscov
pl
pro
enhanc
inhibitori
effect
presenc
nem
result
suggest
potenti
use
three
fdaapprov
drug
combin
treatment
merscov
incident
previou
studi
suggest
mpa
may
use
combin
treatment
interferon
merscov
chan
et
al
experi
repeat
ensur
reproduc
kinet
paramet
k
k
cat
k
bestfit
result
shown
tabl
presenc
disulfiram
bestfit
kinet
paramet
k
determin
accord
competit
eq
mix
inhibit
eq
noncompetit
eq
inhibit
model
sarscov
merscov
pl
pro
respect
c
valu
inhibit
constant
enzymesubstrateinhibitor
complex
k
inact
k
max
valu
best
fit
satur
equat
eq
previou
studi
suggest
disulfiram
bind
zincbound
cystein
hepat
c
viru
protein
lee
et
al
four
cystein
bound
zinc
ion
pl
pro
fig
baileyelkin
et
al
chou
et
al
perform
zinc
eject
assay
test
whether
zincbound
cystein
may
candid
aforement
third
bind
site
occupi
disulfiram
merscov
pl
pro
present
studi
zincspecif
fluorophor
use
identifi
releas
zinc
ion
due
bind
disulfiram
enzym
fig
unexpectedli
observ
signific
zinc
releas
presenc
disulfiram
merscov
pl
pro
also
sarscov
pl
pro
result
indic
disulfiram
may
bind
activ
site
also
zincbind
site
sarscov
pl
pro
follow
find
tri
fit
inhibitori
result
mix
inhibit
model
fig
two
k
enzymesubstr
enzymesubstrateinhibitor
complex
respect
show
differ
bind
affin
two
put
bind
site
tabl
signific
differ
may
explain
inhibitori
pattern
disulfiram
sarscov
pl
pro
look
like
competit
inhibit
next
thermost
two
pl
pro
absenc
presenc
disulfiram
evalu
fig
surprisingli
melt
temperatur
pl
pro
decreas
presenc
disulfiram
result
conform
earlier
find
releas
zinc
ion
destabil
pl
pro
chou
et
al
c
observ
inactiv
rate
constant
k
inact
panel
b
replot
disulfiram
concentr
solid
line
bestfit
result
accord
satur
equat
eq
kinet
paramet
k
inact
k
max
correspond
bestfit
curv
shown
tabl
disulfiram
known
coval
modifi
cystein
residu
leav
diethyldithiolcarbam
ddc
moieti
inactiv
carbam
kinas
giardia
lamblia
galkin
et
al
presenc
mm
howev
inhibitori
effect
disulfiram
pl
pro
minor
ic
larger
tabl
suggest
reduct
protect
enzym
therefor
disulfiram
may
inhibit
enzym
modifi
cystein
catalyt
triad
investig
possibl
dub
activ
enzym
measur
incub
disulfiram
h
follow
remov
small
molecul
use
sephadex
column
treatment
result
loss
activ
suggest
irrevers
inhibit
sarscov
pl
pro
disulfiram
fig
right
panel
similarli
previou
vivo
studi
disulfiramtr
aldehyd
dehydrogenas
show
enzym
inhibit
compar
activ
control
lipski
et
al
next
disulfiramtr
sarscov
pl
pro
incub
mm
min
activ
measur
test
reactiv
found
enzym
activ
restor
treatment
fig
right
panel
rescu
effect
reduct
suggest
modif
due
disulfid
bond
interact
enzym
inhibitor
howev
case
merscov
pl
pro
found
treatment
disulfiram
result
irrevers
loss
activ
rescu
addit
reduct
fig
left
panel
previou
studi
suggest
releas
zinc
ion
follow
treatment
edta
lead
loss
pl
pro
activ
chou
et
al
result
consist
effect
disulfiram
pl
pro
also
inabl
reduct
rescu
dub
activ
merscov
pl
pro
suggest
disulfiram
influenc
activ
site
compat
disulfiram
noncompetit
mode
inhibit
enzym
hand
proteolyt
assay
sarscov
pl
pro
variou
concentr
disulfiram
show
doseand
timedepend
decay
enzym
activ
measur
min
fig
fit
data
eq
differ
k
inact
valu
variou
concentr
disulfiram
determin
plot
versu
disulfiram
concentr
fig
satur
curvatur
suggest
slowbind
phenomenon
due
coval
inactiv
copeland
conclus
support
irrecover
enzym
activ
disulfiram
remov
fig
bestfit
analysi
determin
k
inact
k
max
fig
tabl
interestingli
k
inact
valu
close
k
indic
disulfiram
may
inactiv
enzym
soon
bind
comparison
previou
studi
indic
also
slowbind
inhibitor
enzym
albeit
enzym
activ
recov
remov
inhibitor
chou
et
al
structur
sarscov
pl
pro
complex
disulfiram
allow
us
understand
bind
mechan
clearli
accordingli
attempt
crystal
sarscov
pl
pro
presenc
disulfiram
unfortun
although
crystal
protein
form
presenc
mm
disulfiram
crystal
structur
show
electron
densiti
near
activesit
cystein
omit
electron
densiti
shown
near
zincbind
site
fig
reduc
agent
ad
purif
buffer
stabil
protein
also
known
revers
effect
disulfiram
tabl
fig
kitson
avoid
effect
elimin
reduc
agent
purif
process
ad
disulfiram
purif
buffer
attempt
crystal
protein
purifi
condit
although
abl
grow
crystal
differ
crystal
condit
obtain
unexpect
result
omit
electron
densiti
near
catalyt
site
fit
glycerol
molecul
fig
result
might
due
crystal
cryoprotect
reservoir
solut
supplement
vv
glycerol
nevertheless
bind
glycerol
near
activ
site
suggest
activ
site
may
access
disulfiram
next
use
aforement
two
complex
structur
disulfiram
ddc
molecul
dock
glycerol
bind
site
respect
fig
ddc
may
abl
coval
bind
residu
manner
similar
fig
disulfiram
may
abl
occupi
glycerol
site
fig
interestingli
dock
structur
pl
pro
disulfiram
complex
see
one
sulfur
atom
disulfid
bond
disulfiram
within
residu
block
loop
import
substrat
inhibitor
bind
ratia
et
al
comparison
valin
site
merscov
pl
pro
baileyelkin
et
al
chou
et
al
verifi
possibl
inhibitori
effect
disulfiram
due
bind
residu
inhibit
sarscov
pl
pro
mutant
disulfiram
measur
fig
interestingli
see
increas
ic
tabl
compar
inhibit
wildtyp
sarscov
pl
pro
disulfiram
addit
decreas
melt
temperatur
mutant
follow
treatment
disulfiram
lower
wildtyp
sarscov
pl
pro
treatment
inhibitor
fig
c
find
suggest
disulfiram
may
inhibit
sarscov
pl
pro
partli
via
residu
support
reliabl
dock
disulfiram
glycerol
bind
site
base
kinet
structur
result
propos
kinet
mechan
scheme
inhibit
two
pl
pro
disulfiram
fig
similar
mechan
case
disulfiramtr
ureas
diazsanchez
et
al
disulfiram
may
form
coval
adduct
sarscov
pl
pro
leav
ddc
activesit
prevent
downstream
acyl
therebi
inactiv
fig
bind
disulfiram
sarscov
pl
pro
overlay
model
structur
sarscov
pl
pro
complex
ddc
magenta
disulfiram
orang
b
crystal
structur
sarscov
pl
pro
complex
ubiquitin
gray
pdb
code
ddc
disulfiram
model
base
bind
site
glycerol
respect
red
dash
line
show
put
polar
interact
black
dash
line
show
distanc
residu
disulfiram
interpret
refer
colour
figur
legend
reader
refer
web
version
articl
enzym
contrast
disulfiram
show
noncompetit
inhibitori
effect
merscov
pl
pro
synergist
inhibit
enzym
mpa
studi
found
disulfiram
respect
noncompetit
competit
mix
inhibitor
merscov
sarscov
pl
pro
multipl
inhibit
assay
also
support
kinet
mechan
disulfiram
togeth
andor
mpa
synergist
inhibit
merscov
pl
pro
due
competit
mode
inhibit
sarscov
pl
pro
hand
result
kinet
assay
continu
inactiv
remov
disulfiram
reactiv
reduct
phenomenon
slowbind
inhibit
suggest
disulfiram
may
act
activ
site
sarscov
pl
pro
form
coval
adduct
residu
crystal
structur
enzym
complex
glycerol
impli
activ
site
solventexpos
access
disulfiram
ddc
bind
fig
scheme
propos
kinet
mechan
inhibit
sarscov
merscov
pl
pro
disulfiram
upper
diagram
denot
enzym
catalysi
mix
inhibit
inactiv
sarscov
pl
pro
disulfiram
lower
diagram
show
noncompetit
inhibit
merscov
pl
pro
disulfiram
tripl
inhibit
two
fdaapprov
drug
mpa
sh
symbol
thiolat
catalyt
triad
residu
cy
